分化型甲状腺癌的分子机制。

Molecular mechanisms in differentiated thyroid cancer.

机构信息

Center of Thyroid and Parathyroid, Department of General Surgery, Shanghai Sixth People's Hospital, Shanghai Jiaotong University of Medicine, Shanghai, China.

Center of Thyroid and Parathyroid, Department of General Surgery, Shanghai Sixth People's Hospital, Shanghai Jiaotong University of Medicine, Shanghai, China,

出版信息

Front Biosci (Landmark Ed). 2016 Jan 1;21(1):119-29. doi: 10.2741/4379.

Abstract

Thyroid cancer is a common endocrine malignancy. The tumorigenesis of thyroid tumours has been identified in recent years, including numerous genetic alterations and several major signalling pathways. However, the molecular mechanisms involved in thyroid cancer metastasis remain controversial. Studies in thyroid cancer metastasis suggested that reactivation of several pathways, including epithelial to mesenchymal transition and microenvironment change, may be involved in thyroid cancer migration. The previously identified thyroid oncogenes, BRAF, RET/PTC and Ras, play important roles in regulating the metastatic process. Here, we review the recent knowledge eon molecular mechanisms involved in thyroid cancer metastasis.

摘要

甲状腺癌是一种常见的内分泌恶性肿瘤。近年来已经确定了甲状腺肿瘤的肿瘤发生,包括许多基因改变和几个主要的信号通路。然而,甲状腺癌转移所涉及的分子机制仍存在争议。甲状腺癌转移的研究表明,包括上皮间质转化和微环境改变在内的几个通路的重新激活可能与甲状腺癌的迁移有关。先前鉴定的甲状腺癌基因,如 BRAF、RET/PTC 和 Ras,在调节转移过程中发挥着重要作用。在这里,我们综述了甲状腺癌转移涉及的分子机制的最新知识。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索